نتائج البحث - "Philip J. Johnson"

1

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

المؤلفون: David W G Ten Cate, Robert A. de Man, Heinz-Josef Klümpen, Sarah Berhane, Julien Edeline, Laura J. Bonnett, Jeroen L.A. van Vugt, Ferry A.L.M. Eskens, Alessandro Cucchetti, Jean-Frédéric Blanc, Tim A. Labeur, R. Bart Takkenberg, Dominik Bettinger, Otto M. van Delden, Philip J. Johnson, Tim Meyer

المساهمون: Labeur T.A., Berhane S., Edeline J., Blanc J.-F., Bettinger D., Meyer T., Van Vugt J.L.A., Ten Cate D.W.G., De Man R.A., Eskens F.A.L.M., Cucchetti A., Bonnett L.J., Van Delden O.M., Klumpen H.-J., Takkenberg R.B., Johnson P.J., Surgery, Gastroenterology & Hepatology, Medical Oncology, Graduate School, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, Amsterdam Gastroenterology Endocrinology Metabolism, Cancer Center Amsterdam, Radiology and Nuclear Medicine, Oncology, CCA - Cancer Treatment and Quality of Life, Gastroenterology and Hepatology

المصدر: Liver International, 40(1), 215-228. Wiley-Blackwell Publishing Ltd
Liver international, 40(1), 215-228. Wiley-Blackwell
LIVER INTERNATIONAL
Liver International

وصف الملف: STAMPA; application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3940533462b81f5e1a6c6d7f7fb84aTest
https://doi.org/10.1111/liv.14270Test

2

Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma

المؤلفون: Philip J. Johnson, Matthew Hoare, Tobias Janowitz, Harry Potts, Sarah Berhane, James Tanner, Edward H. Williams, Ruwanthi Kolamunnage-Dona

المصدر: JOURNAL OF HEPATOLOGY

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d617feaf34edf8455900c57ce879071Test

3

Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis

المؤلفون: Philip J. Johnson, Juan W. Valle, Boris Guiu, Richard A Hubner, Mairéad G McNamara, Timothy Jacobs, Julien Edeline, Bas Groot Koerkamp, Angela Lamarca, Daniel H. Palmer

المساهمون: Surgery

المصدر: CANCER TREATMENT REVIEWS
Edeline, J, Lamarca, A, Mcnamara, M G, Jacobs, T, Hubner, R A, Palmer, D, Groot Koerkamp, B, Johnson, P, Guiu, B & Valle, J W 2021, ' Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis ', Cancer Treatment Reviews, vol. 99, 102258 . https://doi.org/10.1016Test/j.ctrv.2021.102258
Cancer Treatment Reviews, 99:102258. W.B. Saunders
Cancer Treatment reviews

مصطلحات موضوعية: Ablation Techniques, Oncology, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Cholangiocarcinoma, Cohort Studies, Clinical Trials, Phase II as Topic, Hepatic Artery, Hepatic arterial infusion, Internal medicine, Humans, Infusions, Intra-Arterial, Medicine, Yttrium Radioisotopes, Radiology, Nuclear Medicine and imaging, External beam radiotherapy, Chemoembolization, Therapeutic, Intrahepatic Cholangiocarcinoma, Randomized Controlled Trials as Topic, Chemotherapy, Manchester Cancer Research Centre, medicine.diagnostic_test, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Interventional radiology, General Medicine, Embolization, Therapeutic, Confidence interval, Pooled variance, Bile Duct Neoplasms, Clinical Trials, Phase III as Topic, Concomitant, business

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf9aa0925685e603ffd5117b7dfa39fTest

4

A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma

المؤلفون: Takashi Kumada, Rubén Amorós, Philip J. Johnson, Ruth King, Hidenori Toyoda, Thomas G. Bird

المصدر: Metron
Amoros Salvador, R, King, R, Toyoda, H, Kumada, T, Johnson, P J & Bird, T G 2019, ' A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma ', METRON, vol. 77, no. 2, pp. 67-86 . https://doi.org/10.1007/s40300-019-00151-8Test

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c8b2d0287c446d57e543347ff97c7aTest
http://europepmc.org/articles/PMC6820468Test

5

Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials

المؤلفون: Philip J. Johnson, Ciro Celsa, Giorgio Ercolani, Giuseppe Cabibbo, Andrea Casadei-Gardini, Alessandro Cucchetti, Giacomo Emanuele Maria Rizzo, Calogero Cammà

المساهمون: Cabibbo G., Cucchetti A., Camma C., Casadei-Gardini A., Celsa C., Emanuele Maria Rizzo G., Johnson P., Ercolani G., Cabibbo, G., Cucchetti, A., Camma, C., Casadei Gardini, A., Celsa, C., Emanuele Maria Rizzo, G., Johnson, P., Ercolani, G.

المصدر: Future Oncology

مصطلحات موضوعية: Sorafenib, Oncology, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Phase iii trials, Antineoplastic Agents, Disease, survival, time to progression, Systemic therapy, systemic therapy, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, meta-regression, medicine, Humans, Clinical Trials, Meta-regression, business.industry, Carcinoma, Liver Neoplasms, Hepatocellular, hepatocellular carcinoma, General Medicine, medicine.disease, Phase III as Topic, Survival Rate, Treatment Outcome, sorafenib, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Meta-analysis, 030211 gastroenterology & hepatology, business, medicine.drug

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74533446800dfe5d336a8961afa6176dTest

6

P-229 Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma

المؤلفون: Daniel H. Palmer, Boris Guiu, Mairéad G McNamara, Angela Lamarca, Richard A Hubner, Timothy Jacobs, Philip J. Johnson, Julien Edeline, Juan W. Valle

المصدر: Annals of Oncology. 32:S177

مصطلحات موضوعية: Oncology, 0303 health sciences, medicine.medical_specialty, business.industry, Hematology, 03 medical and health sciences, 0302 clinical medicine, Pooled analysis, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, business, Intrahepatic Cholangiocarcinoma, 030304 developmental biology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ad1cf4f523e6e2888efd647b73b547dfTest
https://doi.org/10.1016Test/j.annonc.2021.05.283

7

Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma

المؤلفون: Anthony W.H. Chan, John Wong, Philip J. Johnson, Stephen L. Chan, Frankie Mo, Anthony T.C. Chan, Charing C N Chong, Paul B.S. Lai, Winnie Yeo, Ka Fai To, Shuangni Yu

المصدر: Journal of Gastroenterology and Hepatology. 31:1766-1772

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::41e0a23d5d06fe9e885f9a10120adb30Test
https://doi.org/10.1111/jgh.13339Test

8

Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment

المؤلفون: Philip J. Johnson, Sarah Berhane, Richard Fox, Marta García-Fiñana, Alessandro Cucchetti

المصدر: British Journal of Cancer

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13be75dabcfd7569fa76da2b074a6f30Test

9

Trial endpoints for systemic therapy in patients with hepatocellular carcinoma

المؤلفون: Tim Meyer, Philip J. Johnson

المصدر: JOURNAL OF HEPATOLOGY

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Carcinoma, Hepatocellular, Hepatology, business.industry, Liver Neoplasms, MEDLINE, medicine.disease, Systemic therapy, Hepatocellular carcinoma, Internal medicine, Carcinoma, medicine, Humans, In patient, business, Randomized Controlled Trials as Topic

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8c64ff8eb294537deed72af358f789Test
https://pubmed.ncbi.nlm.nih.gov/30943423Test

10

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

المساهمون: Wellcome Trust, Gastroenterology and Hepatology, Graduate School, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, CCA -Cancer Center Amsterdam, CCA - Cancer Treatment and Quality of Life, Han G., Berhane S., Toyoda H., Bettinger D., Elshaarawy O., Chan A.W.H., Kirstein M., Mosconi C., Hucke F., Palmer D., Pinato D.J., Sharma R., Ottaviani D., Jang J.W., Labeur T.A., van Delden O.M., Pirisi M., Stern N., Sangro B., Meyer T., Fateen W., Garcia-Finana M., Gomaa A., Waked I., Rewisha E., Aithal G.P., Travis S., Kudo M., Cucchetti A., Peck-Radosavljevic M., Takkenberg R.B., Chan S.L., Vogel A., Johnson P.J.

المصدر: Hepatology (Baltimore, Md.), 72(1), 198-212. John Wiley and Sons Ltd
Hepatology (Baltimore, Md.)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, EXTERNAL VALIDATION, ARTERIAL CHEMOEMBOLIZATION, Prognostic score, Cohort Studies, 0302 clinical medicine, Training set, Liver Neoplasms, hepatocellular carcinoma, Arteries, Middle Aged, EMBOLIZATION, Prognosis, Survival Rate, DRUG-ELUTING BEADS, 1101 Medical Biochemistry and Metabolomics, 1107 Immunology, Response Evaluation Criteria in Solid Tumors, SAFETY, Hepatocellular carcinoma, Original Article, 030211 gastroenterology & hepatology, Female, Life Sciences & Biomedicine, Adult, medicine.medical_specialty, Carcinoma, Hepatocellular, RETREATMENT, mRECIST, survival, 03 medical and health sciences, Internal medicine, SCORE, medicine, Overall survival, Humans, Internal validation, Chemoembolization, Therapeutic, Aged, TACE, Science & Technology, Models, Statistical, Gastroenterology & Hepatology, Hepatology, business.industry, External validation, 1103 Clinical Sciences, Patient survival, Original Articles, EFFICACY, medicine.disease, 030104 developmental biology, LIVER-FUNCTION, business

وصف الملف: STAMPA; application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e235f3e5de5f59c23131617875d4c68Test
https://pubmed.ncbi.nlm.nih.gov/31698504Test

تنقيح النتائج